Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

JSE/APN stock hub

JSE/APN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

JSE/APNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

65.1B

Johannesburg Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

JSE/APN

In the news

Latest news · JSE/APN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.2

P25 11.2P50 16.2P75 17.1

Trailing P/En/a

P25 6.4P50 15.9P75 23.4

ROE-2.2

P25 -14P50 7.2P75 31.6

ROIC5.6

P25 9.2P50 15.3P75 38.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All JSE/APN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

ZAR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Africa
Country code	ZA
Employees	9,557
Employees Change	207%
Employees Change Percent	2.21
Enterprise value	ZAc 92.4B
Exchange	Johannesburg Stock Exchange
Financial currency	ZAR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	ZAE000066692
Last refreshed	2026-05-10
Market cap	ZAc 65.1B
Price	ZAc 14,665
Price currency	ZAc
Rev Per Employee	4,558,707.05x
Sector	Healthcare
Sic	2834
Symbol	jse/APN
Website	https://www.aspenpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.07%
EV Earnings	-46.24x
EV/EBIT	15.3x
EV/EBITDA	11.79x
EV/FCF	20.89x
EV/Sales	2.17x
FCF yield	6.79%
Forward P/E	16.22x
P/B ratio	0.8x
P/S ratio	1.53x
PE Ratio10 Y	17.85x
PE Ratio5 Y	22.44x
PEG ratio	1.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.19%
EBITDA Margin	17.86%
FCF margin	10.39%
Gross margin	42.99%
Gross Profit	ZAc 18.3B
Gross Profit Growth	-3.9%
Gross Profit Growth Q	-9.07%
Gross Profit Growth3 Y	-1.94%
Gross Profit Growth5 Y	-0.6%
Net Income	ZAc -2B
Net Income Growth Q	-38.36%
Net Income Growth Years	0%
Pretax Margin	-2.61%
Profit Margin	-4.69%
Profit Per Employee	ZAc -213,957
ROA	2.85
Roa5y	4.18
ROCE	5.38
ROE	-2.17
Roe5y	5.43
ROIC	5.57
Roic5y	7.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.4%
Cagr15y	5.25%
Cagr1y	26.08%
Cagr20y	7.72%
Cagr3y	-4.72%
Cagr5y	-0.34%
Div CAGR10	-1.6%
Div CAGR3	-14.87%
Div CAGR5	-4.24%
EPS Growth Q	-38.43
EPS Growth Years	0
FCF Growth	60.87%
FCF Growth Q	302.8%
FCF Growth3 Y	12.49%
FCF Growth5 Y	6.1%
OCF Growth	24.39%
OCF Growth Q	98.17%
OCF Growth10 Y	-0.66%
OCF Growth3 Y	3.65%
OCF Growth5 Y	4.66%
Revenue Growth	2.84x
Revenue Growth Q	-4.32x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.6x
Revenue Growth5 Y	0.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ZAc 0.32
Assets	ZAc 128B
Cash	ZAc 5.6B
Current Assets	ZAc 57.3B
Current Liabilities	ZAc 15.8B
Debt	ZAc 32.9B
Debt EBITDA	ZAc 4.2
Debt Equity	ZAc 0.41
Debt FCF	ZAc 7.45
Equity	ZAc 81.1B
Interest Coverage	3.29
Liabilities	ZAc 47B
Long Term Assets	ZAc 70.7B
Long Term Liabilities	ZAc 31.2B
Net Cash	ZAc -27.3B
Net Cash By Market Cap	ZAc -41.96
Net Debt EBITDA	ZAc 3.59
Net Debt Equity	ZAc 0.34
Net Debt FCF	ZAc 6.18
Tangible Book Value	ZAc 33.7B
Tangible Book Value Per Share	ZAc 75.78
WACC	5.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.64
Inventory Turnover	1.41
Net Working Capital	ZAc 39.5B
Quick ratio	1.03
Working Capital	ZAc 41.6B
Working Capital Turnover	ZAc 1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	-41.23%
Dividend Growth Years	0%
Dividend per share	ZAc 2.11
Dividend Years	5
Dividend Yield	1.44%
Ex Div Date	2025-10-01
Last Dividend	ZAc 2.11
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-48.39%
1Y total return	26.06%
200-day SMA	11,304.7
3Y total return	-13.52%
50-day SMA	13,545.5
50-day SMA vs 200-day SMA	50over200
5Y total return	-1.67%
All Time High	44,868
All Time High Change	-67.32%
All Time High Date	2015-01-27
All Time Low	24.57
All Time Low Change	59,586.61%
All Time Low Date	1998-02-16
ATR	426.3
Beta	0.34
Beta1y	0.39
Beta2y	0.45
Ch YTD	25.57
High	14,799
High52	15,151
High52 Date	2026-05-06
High52ch	-3.21%
Low	14,534
Low52	9,070
Low52 Date	2025-12-11
Low52ch	61.69%
Ma50ch	8.26%
Price vs 200-day SMA	29.72%
RSI	67.06
RSI Monthly	50.94
RSI Weekly	67.02
Sharpe ratio	0.68x
Sortino ratio	1.49
Total Return	1.4%
Tr YTD	25.57
Tr15y	115.5%
Tr1m	9.97%
Tr1w	4.62%
Tr3m	31.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ZAc 6B
Operating Income Growth	-13.6
Operating Income Growth Q	-34.32
Operating Income Growth3 Y	-12
Operating Income Growth5 Y	-7.51
Operating margin	14.19

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	366,101,871%
Net Borrowing	-1,552,000,000
Shares Insiders	17.55%
Shares Institutions	58.83%
Shares Out	444,022,553
Shares Qo Q	0.16%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ZAc 4.3B
Average Volume	1,442,280.85x
Bv Per Share	182.4
CAPEX	ZAc -2.5B
Ch10y	-54.74
Ch15y	81.3
Ch1m	9.97
Ch1w	4.62
Ch1y	23.32
Ch20y	255.3
Ch3m	31.83
Ch3y	-18.6
Ch5y	-10.59
Ch6m	51.5
Change	-0.8%
Change From Open	-0.91
Close	14,783
Days Gap	0.11
Depreciation Amortization	1,565,000,000
Dollar Volume	23,714,947,480
Earnings Date	2026-09-02
EBIT	ZAc 6B
EBITDA	ZAc 7.6B
EPS	ZAc -4.5
F Score	6
FCF	ZAc 4.4B
FCF EV Yield	4.79x
FCF Per Share	ZAc 9.96
Financing CF	-2,499,000,000
Fiscal Year End	June
Founded	1,850
Goodwill	1,261,000,000
Income Tax	ZAc 696M
Investing CF	-4,088,000,000
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Last Split Date	2008-10-06
Last Split Type	Forward
Ma150	11,462.9
Ma150ch	27.93%
Ma20	13,788.3
Ma20ch	6.36%
Net CF	-162,000,000
Next Earnings Date	2026-09-02
Open	14,799
P FCF Ratio	14.72
P OCF Ratio	9.39
Payment Date	2025-10-06
Position In Range	49.43
Ppne	20,550,000,000
Price Date	2026-05-08
Price EBITDA	ZAc 8.56
Ptbv Ratio	1.93
Relative Volume	1.14x
Revenue	42,592,000,000x
SBC By Revenue	0.26x
Share Based Comp	109,000,000
Tax By Revenue	1.63x
Tr20y	342.43%
Tr6m	51.5%
Volume	1,617,112

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

JSE/APN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$2.11 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-4.2%

0 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2025-10-01

Performance

JSE/APN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns JSE/APN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+58.8%

Share of float held by funds and institutions

Insider ownership

+17.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

JSE/APN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.1

Neutral momentum band

Price vs 200-day MA

+29.7%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About JSE/APN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current jse/APN stock rating?

jse/APN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full jse/APN analysis?

The full report lives at /stocks/jse/APN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for jse/APN?

The latest report frames jse/APN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the jse/APN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.